Zhang Ming, Qian Jun, Xing Xianying, Kong Feng-Ming, Zhao Lujun, Chen Ming, Lawrence Theodore S
Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, Michigan 48109-5582, USA.
Clin Cancer Res. 2008 Mar 15;14(6):1868-76. doi: 10.1158/1078-0432.CCR-07-1894.
Radiation-induced lung toxicity limits the delivery of high-dose radiation to thoracic tumors. Here, we investigated the potential of inhibiting the tumor necrosis factor-alpha (TNF-alpha) pathway as a novel radioprotection strategy.
Mouse lungs were irradiated with various doses and assessed at varying times for TNF-alpha production. Lung toxicity was measured by apoptosis and pulmonary function testing. TNF receptor 1 (TNFR1) inhibition, achieved by genetic knockout or antisense oligonucleotide (ASO) silencing, was tested for selective lung protection in a mouse lung metastasis model of colon cancer.
Lung radiation induced local production of TNF-alpha by macrophages in BALB/c mice 3 to 24 hours after radiation (15 Gy). A similar maximal induction was found 1 week after the start of radiation when 15 Gy was divided into five daily fractions. Cell apoptosis in the lung, measured by terminal deoxyribonucleotide transferase-mediated nick-end labeling staining (mostly epithelial cells) and Western blot for caspase-3, was induced by radiation in a dose- and time-dependent manner. Specific ASO inhibited lung TNFR1 expression and reduced radiation-induced apoptosis. Radiation decreased lung function in BALB/c and C57BL mice 4 to 8 weeks after completion of fractionated radiation (40 Gy). Inhibition of TNFR1 by genetic deficiency (C57BL mice) or therapeutic silencing with ASO (BALB/c mice) tended to preserve lung function without compromising lung tumor sensitivity to radiation.
Radiation-induced lung TNF-alpha production correlates with early cell apoptosis and latent lung function damage. Inhibition of lung TNFR1 is selectively radioprotective for the lung without compromising tumor response. These findings support the development of a novel radioprotection strategy using inhibition of the TNF-alpha pathway.
辐射诱导的肺毒性限制了向胸部肿瘤输送高剂量辐射。在此,我们研究了抑制肿瘤坏死因子-α(TNF-α)途径作为一种新型放射防护策略的潜力。
用不同剂量照射小鼠肺部,并在不同时间评估TNF-α的产生。通过凋亡和肺功能测试来测量肺毒性。在结肠癌小鼠肺转移模型中,通过基因敲除或反义寡核苷酸(ASO)沉默实现的TNF受体1(TNFR1)抑制作用,被用于测试选择性肺保护作用。
肺部辐射在辐射后3至24小时(15 Gy)诱导BALB/c小鼠巨噬细胞局部产生TNF-α。当15 Gy分为五个每日分次照射时,在开始辐射1周后发现了类似的最大诱导作用。通过末端脱氧核苷酸转移酶介导的缺口末端标记染色(主要是上皮细胞)和caspase-3的蛋白质印迹法测量的肺细胞凋亡,以剂量和时间依赖性方式由辐射诱导。特异性ASO抑制肺TNFR1表达并减少辐射诱导的凋亡。分次辐射(40 Gy)完成后4至8周,辐射降低了BALB/c和C57BL小鼠的肺功能。通过基因缺陷(C57BL小鼠)或用ASO进行治疗性沉默(BALB/c小鼠)抑制TNFR1倾向于保留肺功能,而不损害肺肿瘤对辐射的敏感性。
辐射诱导的肺TNF-α产生与早期细胞凋亡和潜在的肺功能损害相关。抑制肺TNFR1对肺具有选择性放射保护作用,而不损害肿瘤反应。这些发现支持开发一种使用抑制TNF-α途径的新型放射防护策略。